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Auf1/Hnrnpd-Deficient Mice Develop Pruritic
Inflammatory Skin Disease
Navid Sadri1 and Robert J. Schneider1
Mice lacking heterogenous nuclear ribonuclear protein D (Hnrnpd ), also known as Auf1, a regulator of
inflammatory cytokine mRNA stability, develop chronic dermatitis with age that is characterized by pruritis and
excoriations. Histological analysis showed marked epidermal acanthosis and spongiosis, neovascularization,
and elevated number of inflammatory cells, including T cells, macrophages, neutrophils, mast cells, and
eosinophils. Hnrnpd-deficient (Hnrnpdtm1Rjsc) mice with dermatitis display elevated serum IgE levels. Lesions in
Hnrnpdtm1Rjsc mice were associated with a shift towards a Th2 immune environment. Evaluation of T-cell-
mediated skin inflammation by assaying contact hypersensitivity indicated an increased response in
Hnrnpdtm1Rjsc mice. T cells and macrophages from Hnrnpdtm1Rjsc mice demonstrate a number of abnormalities
associated with dermatitis, including increased IL2, tumor-necrosis factor-a (TNFa), and IL1b production. Finally,
many features of spontaneous dermatitis could be recapitulated in experimentally induced lesions by
subcutaneous injection of CCL27 and TNF in unaffected Hnrnpdtm1Rjsc mice. Collectively, these data highlight
the importance of HNRNPD and proper regulation of mRNA stability in the intricate processes of leukocyte
recruitment and inflammatory activation within the skin.
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INTRODUCTION
Atopic dermatitis (AD) is a common chronic pruritic
inflammatory disease that typically occurs in early childhood,
but it can persist into or present in adulthood (Leung et al.,
2004; Boguniewicz et al., 2006). AD is often associated with
subsequent development of other atopic conditions, such as
asthma and allergic rhinoconjunctivitis (Leung et al., 2004;
Boguniewicz et al., 2006). Both genetic and environmental
factors are important in the development of the disease
(Leung et al., 2004; Hoffjan and Epplen, 2005). The etiology
of the disease is unknown, although 70–80% of AD patients
have elevated serum IgE levels suggesting an association with
an allergic response (Leung et al., 2004). Treatment of AD is
largely limited to antiinflammatory drugs, such as cortico-
steroids, that show transient effect on symptoms. A better
understanding of the mechanisms underlying the etiology and
chronic nature of the disease is critical for development of
more effect therapeutic strategies.
The pathophysiology of AD involves complex interactions
among the host’s environment, the skin’s barrier functions, as
well as systemic and local immunological responses orche-
strated by inflammatory cytokines and chemokines (Leung
et al., 2004; Avgerinou et al., 2008). A large number of these
inflammatory cytokines, including IL1, IL4, IL5, IL10, IL12,
IL13, IL17, IFN-g, and tumor-necrosis factor-a (TNFa), are
encoded by mRNAs that contain AU-rich elements (ARE) in
their 30-untranslated region (Halees et al., 2008). The ARE
through the interaction with ARE-binding proteins governs
the stability and translation of its corresponding mRNA
(Barreau et al., 2005). Heterogeneous nuclear riboncleopro-
tein D (HNRNPD), commonly referred to as ARE/poly-(U)
binding degradation factor 1 (Auf1), is an ARE-binding
protein that is important in the regulation of ARE-mRNA
stability (Barreau et al., 2005; Lu et al., 2006). We have
previously shown that disruption of Hnrnpd gene expression
in an engineered knockout mouse model, Hnrnpd tm1Rjsc,
sensitizes mice to endotoxic shock and increased mortality as
a result of an increased and prolonged TNF and IL1b-
mediated proinflammatory response (Lu et al., 2006). This
study demonstrates the physiological role of HNRNPD in
regulating the expression of ARE-containing mRNAs and
highlights the consequence on immunological responses
when this regulation is lost. HNRNPD is not only highly
expressed in immune cells (Lu and Schneider, 2004) but also
shows strong staining in the skin (Figure S1b). Thus we
hypothesized that in response to environmental triggers, the
activation and inability to attenuate inflammatory pathways
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would result in inflammatory dermatoses in Hnrnpd tm1Rjsc
mice.
Here we show that Hnrnpd tm1Rjsc mice develop chronic
pruritic eczematous skin dermatitis that resembles some
clinical and histological features of human AD. Hnrnpd tm1Rjsc
mice exhibit enhanced contact hypersensitivity (CHS) char-
acterized by marked increase in T lymphocytes and macro-
phages infiltration, as well as a significant increase in
proinflammatory cytokines. Finally, recruitment of T cells in
a proinflammatory environment, created by subcutaneous
injection of TNF and CCL27, resulted in eczematous lesions
in Hnrnpd tm1Rjsc mice but not in wild-type littermates. These
lesions share many features of spontaneous dermatitis seen in
Hnrnpd tm1Rjsc mice, suggesting an important role of T-cells
concomitant with a proinflammatory environment in the
etiology of these lesions in mice lacking Hnrnpd.
RESULTS
Hnrnpd tm1Rjsc mice develop spontaneous inflammatory skin
lesions
Hnrnpd tm1Rjsc mice exhibit signs of cutaneous periocular
changes around 2–3 months of age that develop into pruritic
erythematous ulcerative lesions primarily located on the face,
rostrum, ear, and neck. The majority of lesions invariably
begin with palpebral swelling (Figure 1b and c). The initial
blepharitis is later accompanied with periocular edema that
often results in palpebral closure, as well as serous exudates
and crust formation (Figure 1d). Lesions invariably progress
below the eye (Figure 1e) and continue to spread to the neck
in severely affected mice (Figure 1f). This progression is
believed to be a result of excoriation, as affected mice scratch
intensely at sites of lesions. Chronic lesions are characterized
by lichenification of the skin with scaly white appearance
(Figure 1g and h). About 25% of affected animals present with
crust formation and ulcers on the pinna, external ear canal
(Figure 1i), or dorsum rather than with periocular lesions.
Blepharitis and dermatitis are restricted to homozygote
Hnrnpd tm1Rjsc mice, as heterozygous and wild-type litter-
mates are free of disease. To facilitate the description of the
phenotype, a ‘‘skin lesion’’ was categorized as involvement
of tissue outside of palpebral involvement upon gross
examination (refer to Figure 1e–i). A lesion includes both
contiguous spread to surrounding tissue from periocular
involvement and dermatitis in locations distant from or
without periocular involvement. Age of onset and incidence
of skin lesions is shown in Figure 1j. 129S6/SvEvTac (129S6)-
Hnrnpd tm1Rjsc mice show earlier onset and higher incidence
of skin lesions than B6;129S6-Hnrnpd tm1Rjsc mice (Figure 1j).
However no differences were observed in the gross pathology
or histological analysis of lesions from these two back-
grounds. The sex of the animals had no impact on the onset,
incidence, or severity of disease. Owing to the size of our
129S6-Hnrnpd tm1Rjsc mouse colony, studies and analysis
described in this report were performed in B6;129S6-
Hnrnpd tm1Rjsc mice and wild-type sex-match littermates
were used as controls, unless otherwise stated. Preliminary
studies performed in 129S6-Hnrnpd tm1Rjsc mice mirror the
results seen in CHS experiments and in characterization of
inflammatory cells carried out in B6;129S6-Hnrnpd tm1Rjsc
mice.
Two independently bred populations of Hnrnpd tm1Rjsc
mice in separate animal facilities maintained by clean animal
husbandry protocols developed spontaneous lesions at
similar frequencies and rates. In approximately 15% of cases,
bacterial pyoderma containing staphylococcal colonies were
found on denuded surfaces of skin lesions by histological
examination. However, bacterial colonies were not found in
the dermis or in other organs. Histological examination may
underestimate the presence of staphylococcus in skin lesions as
bacterial cultures of chronic lesions in three Hnrnpd1tm1Rjsc
mice tested were all positive for Staphylococcus aureus.
Affected Hnrnpd tm1Rjsc mice were unresponsive to topical
and oral antibiotics, although lesions showed improvement in
response to subcutaneous and topical corticosteroid treat-
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Figure 1. Appearance and incidence of dermatitis in Hnrnpd tm1Rjsc mice. (a)
Wild-type mouse (12-month old). (b–f) Representative pictures of increasing
progression of disease severity in Hnrnpd tm1Rjsc mice; (b, c) 3-month old with
blepharitis and periocular edema; (d) 5-month old with severe blepharitis,
serous exudates, and crust formation; (e, f) 6-month old with lesions spread to
contiguous tissue and associated with excoriations and crusting. (g–i) Chronic
lesions in 12-month-old Hnrnpd tm1Rjsc mice associated with lichenification,
erosion, crusting, and excoriations. (j) Incidence of dermatitis in B6;129S6-
Hnrnpd tm1Rjsc mice (n¼34, solid black), B6;129S6 wild-type and
heterozygote mice (n¼ 31, dotted black), 129S6-Hnrnpd tm1Rjsc mice (n¼ 21,
solid blue), and 129S6 wild-type and heterozygote mice (n¼ 24, dotted blue).
‘‘Skin lesions’’ were categorized as dermatitis beyond palpebral involvement,
refer to (e–i). *Po0.0001.
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ment. Improvement was not permanent, as lesion severity
returned with cessation of immunosuppressive treatment.
Histological examination of lesions
Histological examination of normal skin from Hnrnpd tm1Rjsc
mice with lesions revealed normal epidermal thickness and a
trace of mononuclear cells in the dermis (Figure 2a).
However, histological analysis of skin neighboring lesions
showed a large dermal infiltration of neutrophils, mono-
nuclear cells, and a few eosinophils with minimal epidermal
morphological changes (Figure 2b and c), suggesting
leukocyte infiltration precedes epidermal proliferation in
disease progression. Histological examination of chronic skin
lesions demonstrates marked acanthosis of the epidermis with
spongiosis, hyperkeratosis with focal areas of parakeratosis,
and prominent dermal and epidermal infiltration of leuko-
cytes (Figure 2d–g). Phosphorylation of the signal transducer
and activator of transcription 3 (Stat3) at Tyr705 (PY-Stat3) is
seen in psoriatic lesions (Sano et al., 2005) and animal
models of induced epidermal hyperplasia (Chan et al., 2004).
To further characterize the epidermal changes we looked at
PY-Stat3 staining in affected Hnrnpd tm1Rjsc mice. No staining
was seen in unaffected skin (Figure S1c). In contrast, the
thickened epidermis in acute lesions (Figure 2h) and skin
neighboring lesions (Figure S1d) demonstrate strong PY-Stat3
staining. Increased neovascularization is seen by the large
number of capillaries present close to dermoepidermal
junction (Figure 2e) and as can be visualized by antibodies
to CD31 (Figure 2i). Neutrophil aggregates composed of
mounds of pykotic neutorphilic debris and eosinophilic
serum can be seen above parakeratotic stratum corneum
(Figure 2e and g). In addition to aggregates, neutrophil
infiltration within the epidermis and dermis can be seen by
antibodies to Gr-1 (Figure 2j). Staining for T cells demon-
strates a large dermal infiltration and occasional epidermal
infiltrate (Figure 2k). Antibodies to F4/80 demonstrate dermal
macrophage infiltrate (Figure 2l). A moderate degree of
eosinophil infiltration can be seen in chronic lesions (Figure
2m). Numerous dermal mast cells, some of which show
degranulation, are evident in chronic lesions (Figure 2n) and
the number mast cells correlate with chronicity of the lesion.
Mast cell degranulation is caused by crosslinking of IgE
receptors (Navi et al., 2007), thus we measured IgE serum
levels in affected Hnrnpd tm1Rjsc mice. Although no significant
difference was seen between the serum IgE levels in wild-type
(0.7±0.3 mg ml1) and unaffected Hnrnpd tm1Rjsc
(1.2±0.4 mg ml1) mice 8–12 months of age, Hnrnpd tm1Rjsc
mice of the same age with chronic dermatitis (CD) had
significantly higher serum IgE levels (7.9±5.5 mg ml1)
(Figure 2o). Furthermore, the inflammation in lesions in
Hnrnpd tm1Rjsc mice was associated with a shift towards a Th2
immune environment as was indicated by the decrease in
IFN-g (Th1-specific cytokine) mRNA relative to IL4 (Th2-
specific cytokine) mRNA levels as compared to control
biopsies from wild-type littermates (Figure 2p). The shift was
observed in all periocular biopsies taken from affected
Hnrnpd tm1Rjsc mice, with biopsies from earlier disease (mild
blepharitis) displaying a greater Th2 shift than biopsies taken
from more progressed lesions (Figure 2p). In contrast, biopsies
taken from unaffected ears of the same Hnrnpd tm1Rjsc mice
showed no differences as compared to ears form wild-type
littermate ears. In addition, biopsy of a Hnrnpd tm1Rjsc ear
affected by dermatitis also exhibited a similar Th2 shift. These
results suggest that the onset and early progression of lesions
is associated with a shift towards a Th2 environment in
Hnrnpd tm1Rjsc mice.
Increased contact hypersensitivity response in Hnrnpd tm1Rjsc
mice
Given the eczematous and inflammatory nature of skin
lesions in Hnrnpd tm1Rjsc mice, we next sought to investigate
the CHS response, a good experimental model for T-cell-
derived, cytokine-mediated skin inflammation (Watanabe
et al., 2002). Sensitized Hnrnpd tm1Rjsc mice exhibit increased
ear swelling and dense mononuclear cell infiltrate (Figure
3a–c) 24 hours after elicitation with DNFB as compared to
wild-type littermate controls. No ear swelling was exhibited
in nonsensitized Hnrnpd tm1Rjsc mice and wild-type littermate
controls treated with DNFB (Figure 3c), excluding the
possibility that the increase in ear thickness was a result of
irritation. The numbers of infiltrating macrophages and T
cells, but not neutrophils were significantly increased in
Hnrnpd tm1Rjsc ears 24 hours after elicitation as compared to
that in wild-type controls (Figure 3d–f). To better characterize
the nature of the response, inflammatory cytokine and
chemokine levels in DNFB-elicited ears were assessed by
quantitative (q) reverse transcriptase (RT)-PCR. The mRNA
levels of TNF, IL1b, IL2, and monocyte chemoattractant
protein 1 (MCP1; also known as CCL2) were significantly
increased, whereas IL1 receptor antagonist (IL1Ra) mRNA
levels were substantially reduced in the ears of Hnrnpd tm1Rjsc
mice (Figure 3g). The importance of TNF, IL1b, MCP1, and
IL1Ra in regulating the CHS response and skin inflammation
has been well established (Kondo et al., 1995; Mizumoto
et al., 2001; Wang et al., 2003), validating and providing
mechanistic insight into the enhanced CHS response seen in
Hnrnpd tm1Rjsc mice. Furthermore, characterization of IFN-g
and IL4 mRNA levels in DNFB-elicited ears from
Hnrnpd tm1Rjsc mice suggests a shift towards a Th2 response
as compared to that observed in wild-tye littermates. There
was a fourfold decrease in the ratio of IFN-g mRNA levels
relative to IL4 mRNA levels in DNFB-elicited ears from
Hnrnpd tm1Rjsc mice as compared to wild-type littermates
(Figure 4h). In contrast, there was a threefold increase in the
ratio of IFN-g mRNA levels relative to IL4 mRNA levels in
DNFB-elicited ears from Hnrnpd tm1Rjsc mice with CD.
To further delineate the role of HNRNPD in afferent and
efferent phases of the CHS response, adoptive transfer
experiments were performed. Hnrnpd tm1Rjsc and wild-type
littermate donors were sensitized with DNFB. After 5 days,
pooled purified T cells from draining lymph nodes of each
group of sensitized mice were injected into the base of the ear
of naı¨ve wild-type mice. Cells from Hnrnpd tm1Rjsc mice were
injected into the right ear and wild-type cells into the left ear
of each recipient mouse. The recipient mouse was then
immediately challenged with DNFB and ear thickness was
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Figure 2. Histopathology of lesions. (a–e) Hematoxylin/eosin (H/E) staining of skin sections taken from the dorsum of the same 11-month-old Hnrnpdtm1Rjsc mouse with
chronic lesions at 2cm from lesion (a), 1cm from lesion (b, c), and at the lesion (d, e). (c, e) are enlarged magnification of rectangle in (b, d), respectively. (a) Non-lesion
skin in Hnrnpd tm1Rjsc mice normally consists of one or two epidermal layers overlaying a noninflammed dermis. (b, c) Skin neighboring lesion shows (c) large infiltration of
neutrophils, mononuclear cells, and a few eosinophils (arrows) without discernable epidermal changes. (d, e) Chronic lesions show marked epidermal acanthosis with
spongiosis, hyperkeratosis, parakeratosis, prominenet dermal infiltrate, and neocascularization. Arrows in (e) highlight capillaries near dermoepidermal border. (f, g)
Representative H/E sections from other chronic lesions from ear (f) and face (g) of 10-month-old Hnrnpd tm1Rjsc mice showing similar changes. Insert in (f) shows an
example of spongiosis, and in (g) shows an example of leukocyte infiltrate in the epidermis (arrows). (e, g) Neutrophil aggregates composed of pykotic neutrophilic debris,
eosinophilic serum, and occasional staphylococcal colonies (*) located above parakeratotic stratum corneum are seen in severe chronic lesions. (h) Acute lesions
demonstrate strong PY-Stat3 staining (brown). (i–l) Immunostaining of a chronic lesion from facial skin demonstrating (i) neovascularization (CD31þ , blue), (j) infiltrate of
dermal and epidermal abscess of neutrophils (Gr-1þ , blue), (k) dermal and epidermal (arrowheads) T cells (CD3þ , brown), and (l) dermal macrophages (F4/80þ , brown).
(m) Staining by 3,30-diaminobenidine plus nickel chloride (DAB-Ni) demonstrates the presence of eosinophils (arrows) in dermis of chronic lesions. (n) Toluidine blue
staining demonstrates large number of dermal mast cells in chronic lesions. Scale bar¼ 0.1mm. (o) Serum IgE levels were tested by ELISA from 8- to 12-month-old wild-
type mice (white), and Hnrnpd tm1Rjsc mice free of lesions (black) or with chronic dermatitis (CD, gray). (p) Ratio of IFN-g mRNA levels relative to IL4 mRNA levels in
periocular and ear biopsies from Hnrnpd tm1Rjsc with dermatitis and wild-type controls. Biopsies taken from sites with overt dermatitis or blepharitis are shaded in gray.
Each circle represents values from an independent biopsy. Periocular biopsies were taken from both eyes in Hnrnpd tm1Rjsc mice and left eye in wild-type littermates. Five
mice were surveyed for each genotype. Numbers in red on the graph and corresponding images (right) represent examples of lesions surveyed. *Po0.02, **Po0.001.
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measured 24 hours later. There was a slight but not significant
increase in the ear thickness in ears receiving Hnrnpd tm1Rjsc
T cells as compared to those receiving wild-type T cells
(54.8±2.6 vs 51.8±2.2 102 mm; Figure 4a–c). We next
assessed the effect of HNRNPD deficiency on the efferent or
elicitation phase. Pooled purified T cells from draining lymph
nodes of DNFB sensitized wild-type mice were injected into
the base of right ears of naı¨ve Hnrnpd tm1Rjsc and wild-type
littermate recipient mice. As a control, the left ears were
injected with purified T cells from lymph nodes of naı¨ve wild-
type mice. After transfer the ears of the mice were challenged
with DNFB and ear thickness was measured. There was an
increase in ear thickness in Hnrnpd tm1Rjsc recipients of
sensitized wild-type T cells as compared to wild-type
recipients (55.9±2.3 vs 49.6±2.2102 mm, Po0.05;
Figure 4d, e and h). DNFB-challenged left ears of recipient
Hnrnpd tm1Rjsc and wild-type mice receiving T cells from
naı¨ve wild-type mice did not exhibit a CHS response (Figure
4f–h), excluding an irritation response as a source of ear
swelling. These findings suggest that the increased CHS
response in Hnrnpdtm1Rjsc mice is primarily due to an
enhanced efferent phase of the CHS response. This is
concordance with the prolonged and increased production
of TNF and IL1b, key effectors of the efferent phase of CHS
(Nakae et al., 2003; Wang et al., 2003), in inflammatory cells
from Hnrnpd tm1Rjsc mice (Lu et al., 2006).
p38 MAPK activation is required for increased CHS in
Hnrnpd tm1Rjsc mice
The p38 mitogen-activated protein kinase (MAPK) has been
demonstrated to be important in skin inflammatory diseases,
CHS in mice (Takanami-Ohnishi et al., 2002), and serves as a
therapeutic target for a variety of inflammatory diseases
(Kumar et al., 2003). The p38 MAPK controls inflammation in
part by regulating ARE-mediated mRNA decay (Takanami-
Ohnishi et al., 2002). Therefore, we next evaluated the effect
of pharmacological inhibition of the p38 MAPK with
SB203580 (Kumar et al., 2003) on CHS elicitation in
sensitized-Hnrnpd tm1Rjsc mice. Pretreatment of sensitized
mice with SB203580 before elicitation had a much greater
antiinflammatory effect on the CHS response elicited in
Hnrnpd tm1Rjsc mice as compared to wild-type littermates
(Figure 5). The difference in ear thickness between ears
pretreated with SB203580 and vehicle alone in Hnrnpd tm1Rjsc
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Figure 3. Increased CHS in Hnrnpd tm1Rjsc mice. (a, b) H/E-stained section of ears collected 24 hours post-DNFB elicitation from DNFB-sensitized (a) wild-type
(WT) and (b) Hnrnpd tm1Rjsc (KO) littermates. Scale bar¼ 0.2 mm. (c) Ear thickness 24 hours post-DNFB elicitation in naı¨ve or DNFB-sensitized WT and KO
littermates. Each diamond or circle represents measurements of one mouse and red bar represents the mean in each group. (d, e) Counts of the number of (d)
macrophages (F4/80þ ), (e) T cells (CD3þ ), and (f) neutrophils per high-power field (HPF,  400 magnification) in DNFB-elicited ears from DNFB-sensitized
control WT and KO littermates. (g) Relative mRNA levels in ears of DNFB-sensitized wild-type mice (white bars) and Hnrnpd tm1Rjsc littermates (black bars)
24 hours post-DNFB elicitation as determined by qRT-PCR. Each bar represents mean±SD of six mice. (h) Ratio of IFN-g mRNA levels relative to IL4 mRNA
levels in ears of DNFB-sensitized wild-type mice (white), Hnrnpd tm1Rjsc littermates (black), and Hnrnpd tm1Rjsc mice with chronic dermatitis (CD, gray) 24 hours
post-DNFB elicitation. *Po0.05, **Po0.01.
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mice was twofold greater than the difference seen in wild-
type mice (Figure 5a). Similarly the increase in mRNA levels
of IL1b, IL6, and MCP1 exhibited post-CHS elicitation in
Hnrnpd tm1Rjsc mice was reduced to levels comparable or
below that seen in wild-type controls when Hnrnpd tm1Rjsc
mice were pretreated with SB203580 before elicitation with
DNFB (Figure 5b). Hence p38 MAPK inhibitors currently in
clinical trails may hold even greater therapeutic potential in
the treatment of inflammatory diseases, including inflamma-
tory dermatoses, accompanied by loss-of-function Hnrnpd
mutations.
Hnrnpd-deficient T cells are hyperproliferative
Given the importance of T cells in CHS and eczematous
dermatitis in animal models (Leung et al., 2004), we assessed
the effect of Hnrnpd deficiency on T-cell proliferation. T cells
from unaffected animals were labeled with carboxyfluores-
cein diacetate succinimidyl ester (CSFE), then stimulated by
TCR activation and analyzed by flow cytometry to assess cell
division. T cells from Hnrnpd tm1Rjsc mice, particularly CD4þ
cells, divide more readily than wild-type T cells (Figure 6a).
This difference is largest at lower levels of TCR activation. For
example, at 72 hours after stimulation with 0.2 mg ml1 of
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Figure 4. CHS in naı¨ve mice adoptively transferred with DNFB-sensitized T cells. (a–c) Hnrnpd tm1Rjsc mice and wild-type littermates were sensitized with 0.5%
DNFB and T cells from draining lymph nodes were harvested 5 days later. Pooled T cells were injected into the base of the ear of naı¨ve wild-type mice
and subsequently ears were challenged with 0.2% DNFB. (a, b) Representative H/E-stained section of ears collected 24 hours post-DNFB elicitation from the
same mouse. T cells from DNFB-sensitized wild-type mice were injected into the left ear (a) and T cells from DNFB-sensitized Hnrnpd tm1Rjsc littermates were
injected to the right ear (b). (c) Ear thickness 24 hours after elicitation with vehicle alone (vehicle, n¼ 2) or DNFB (n¼ 4) in naı¨ve wild-type mice injected with
T cells from DNFB-sensitized wild-type mice (white bar) and Hnrnpd tm1Rjsc littermates (black bar). (d–h) Wild-type mice were sensitized with 0.5% DNFB and
T cells from draining lymph nodes were harvested 5 days later. Pooled T cells were injected into the base of the right ear of naı¨ve Hnrnpd tm1Rjsc mice and
littermate wild-type mice and ears were subsequently challenged with 0.2% DNFB. As a control, T cells from naı¨ve wild-type mice were injected into the left
ears of recipient mice before challenge. Representative H/E-stained section from (d) right (receiving sensitized T cells; ‘sensitized,’ white bar in (h)) and
(f) left (receiving naı¨ve T cells; ‘naı¨ve,’ white bar in (h)) ears of a wild-type mouse and from (e) right (‘sensitized,’ black bar in (h)) and (g) left (‘naı¨ve,’ black bar in
(h)) ears of a Hnrnpd tm1Rjs littermate 24 hours post-DNFB elicitation. (h) Plot of ear thickness 24 hours post-DNFB elicitation. Scale bar¼0.2 mm. Histograms
represent mean±SD of four mice. *Po0.05.
IL1RaMCP1
veh SBveh SBveh SBveh SB
IL6IL1
**
** *
*
* KOWT
0
2
4
6
8
R
el
at
ive
 m
R
N
A 
le
ve
ls
KOWT
SB203580Vehicle
30
40
50
60
Ea
r t
hi
ck
ne
ss
 (1
0–
2  
m
m
)
Figure 5. p38 MAPK inhibition blocks enhanced CHS in Hnrnpd tm1Rjs mice. (a) Ear thickness 24 hours post-DNFB elicitation from wild-type (WT; white bar)
and Hnrnpd tm1Rjsc (KO; black bar) littermates that were either pretreated with vehicle or p38 MAPK inhibitor, SB203580, 30 minutes before elicitation.
(b) Relative mRNA levels as determined by qRT-PCR 24 hours post-DNFB elicitation in ears from WT and KO littermates that were either pretreated with vehicle
(veh) or SB203580 (SB) 30 minutes before elicitation. Histograms represent mean±SD of three mice. The change between vehicle and inhibitor for each mouse
was determined. Those differences were compared between KO and WT groups. *Po0.05, **Po0.01.
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antibody to CD3, 19% of CD4þ cells from Hnrnpd tm1Rjsc
mice entered their third division compared to only 10% of
wild-type CD4þ cells. In complementary experiments,
isolated splenic CD4þ T cells show increased [3H]thymidine
incorporation after stimulation (Figure 6b). In both assays, the
greatest differences were observed in lower doses of an
antibody to CD3, suggesting that CD4þ T cells from
Hnrnpd tm1Rjsc mice are more readily activated under
suboptimal stimulation conditions. In accordance with these
results, T cells from Hnrnpd tm1Rjsc mice produce significantly
higher levels of IL2 than T cells from wild-type littermates in
response to TCR activation (Figure 6c). This increase is
detectable within 24 hours, at a time when it is evident by
CSFE analysis that proliferation has not taken place. Silencing
of HNRNPD expression in Jurkat T cells by shRNA results in a
similar twofold increase in IL2 production as compared to
Jurkat T cells treated with control knockdown vector (Figure
6d). Thus, the increase in IL2 production is dependent upon
loss of Hnrnpd expression and is not a result of develop-
mental differences of T cells in Hnrnpd tm1Rjsc mice.
Increased recruitment of Hnrnpd tm1Rjsc macrophages to sites of
inflammation
Given the enhanced number of dermal macrophages in the
CHS response and in skin lesions of Hnrnpd tm1Rjsc mice, we
assessed the recruitment of macrophages to sites of inflam-
mation in Hnrnpd tm1Rjsc mice by using a thioglycollate-
induced peritonitis model. Although no difference was seen
in the number of resident macrophage populations between
Hnrnpd tm1Rjsc and wild-type mice, thioglycollate treatment
resulted in a 60% increase in the number of F4/80þ
peritoneal macrophages in Hnrnpd mice (Figure 7a). This
increase was even evident in 129S6-Hnrnpd tm1Rjsc mice
(Figure 7b), a strain that has been reported to have a sharp
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the population of nondividing T cells. Numbers indicate the percentage of cells that have entered at least two rounds of cell division. (b) TCR-induced
[3H]thymidine incorporation. Splenic CD4þ isolated T cells from 4-month-old wild-type (white bar) and Hnrnpd tm1Rjsc (black bar) littermates were left
unstimulated (unstim) or were stimulated with antibody to CD3 (concentrations, mg ml1, horizontal axis) with or without IL2 (I, 100 U) and antibody to CD28
(C, 1 mg ml1) for 48 hours. [3H]thymidine incorporation is presented as mean±SD of triplicate wells. (c) IL2 ELISA. Splenocytes from 4-month-old wild-type
(white) and Hnrnpd tm1Rjsc (black) littermates were stimulated with titrating concentrations of antibody to CD3 for 24 hours. Supernatants were collected and
IL2 levels were measured by ELISA. Data are presented as mean±SD of three independent experiments. (d) HNRNPD expression (top and left) by flow
cytometry analysis in HNRNPD-knockdown (gray) and control-knockdown (bold) Jurkat T cells or by immunoblot analysis (top and right). In immunoblot
analysis, staining with HNRNPD shows three bands (arrowheads) corresponding to the four isoforms of AUF1. Levels of other ARE-binding proteins, HuR and
TIAR, are shown as controls. IL2 ELISA (bottom), control-knockdown (white), and HNRNPD-knockdown (black) Jurkat T cells were stimulated with antibody to
CD3 (1 mml1) or phorbol myristate acetate (PMA; 10 ng ml1) for 24 hours and secreted IL2 production was measured. Data are presented as mean±SD of two
independent experiments. *Po0.05, **Po0.01.
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defect in macrophage recruitment (White et al., 2002).
Furthermore, 8 hours post-intraperitoneal (i.p.) lipopoly-
saccharide (LPS) challenge, Hnrnpd tm1Rjsc mice showed a
65% increase in the number of peripheral blood monocytes
(Figure 7c), which coincides with a twofold increase in serum
MCP1 levels at 4 hours after challenge. These data, in
addition to CHS response studies, suggest that in
Hnrnpd tm1Rjsc mice there is an increase in the recruitment
of macrophages to sites of inflammation, including the skin,
in part due to increased MCP1 levels.
Subcutaneous injection of CCL27 and TNF in Hnrnpd tm1Rjsc
mice results in inflammatory lesions similar to spontaneous
eczematous dermatitis
To directly assay the role of T cell and macrophage
recruitment in the formation of lesions seen in Hnrnpd tm1Rjsc
mice, we injected mice with macrophage and skin
T-lymphocyte homing chemokines, MCP1, and CCL27,
respectively (Homey et al., 2002; Wang et al., 2006).
Unaffected Hnrnpd tm1Rjsc and wild-type littermates were
injected subcutaneously with MCP1 alone, MCP1 and TNF,
CCL27 alone, CCL27 and TNF, TNF alone, or phosphate-
buffered saline (PBS) as a control. Although no lesions were
observed in wild-type mice, sites on Hnrnpd tm1Rjsc mice
injected with MCP1 alone, MCP1 and TNF, or CCL27 and
TNF, resulted in inflammatory lesions (Figure 8; Figure S2a).
It has been demonstrated in mice that T lymphocytes can
be attracted to the skin by subcutaneous injection of CCL27
(Homey et al., 2002). Injection of CCL27 resulted in a large
number of dermal T cells but did not result in epidermal
changes (Figure S2b). However, sites injected with CCL27
and TNF resulted in inflammatory lesions in Hnrnpd tm1Rjsc
mice. These lesions histologically resembled chronic spon-
giotic dermatitis, and were accompanied by a large infiltra-
tion of T lymphocytes and macrophages (Figure 8a–c). These
lesions shared many similarities to chronic lesions seen in
Hnrnpd tm1Rjsc mice, including marked acanthosis of the
epidermis, hyperkeratosis, increased dermal capillary forma-
tion (Figure 8a and m), PY-Stat3 staining (Figure S2c), and
large infiltrate of mast cells (Figure 8o). In contrast, infiltration
of T cells and macrophages could be seen at sites of
simultaneous injection of CCL27 and TNF in wild-type
littermate controls although no epidermal changes were
observed (Figure 8d–f).
Injection of MCP1 (Figure 8g–i) or MCP1 and TNF (Figure
S2a, Figure 8n) also resulted in inflammatory lesion formation
in Hnrnpd tm1Rjsc mice. Injection of MCP1 resulted in epidermal
changes and massive infiltration of macrophages and T cells in
Hnrnpd tm1Rjsc mice (Figure 8g–i). In contrast, injection of MCP1
in wild-type mice resulted in a robust macrophage infiltrate but
virtually no T cells (Figure 8j–l). We speculate that recruited
macrophages in Hnrnpd tm1Rjsc mice are unable to properly
regulate their proinflammatory response, leading to a cyclical
amplification of inflammatory processes including T-cell
recruitment and epidermal changes. Histological examination
of lesions at sites of MCP1 injection however showed a number
of differences from lesions seen in Hnrnpd tm1Rjsc mice. Lesions
caused by MCP1 injection histologically resemble interface
dermatitis with a large inflammatory cell infiltrate (Figure 8g
and n) and in extreme cases, exhibit vacuolar formation at the
dermoepidermal junction (Figure 8n). Furthermore, these
lesions show a smaller degree of epidermal acanthosis and
hyperkeratosis, no PY-Stat3 staining (Figure S2c), and a smaller
number of mast cells as compared to lesions formed by
injection of CCL27 and TNF (Figure 8o). These studies suggest
that the order of leukocyte recruitment may be important in
lesion formation. Furthermore, they suggest that T-cell recruit-
ment concomitant with an inflammatory trigger, such as TNF
secretion, are important in causing the lesions seen in
Hnrnpd tm1Rjsc mice.
DISCUSSION
Hnrnpd tm1Rjsc mice develop eczematous lesions which share
several features resembling human AD. The skin disease seen
in Hnrnpd tm1Rjsc mice fulfills three major diagnostic criteria,
including pruritus, CD, and family history of cutaneous atopy
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Figure 7. Increased macrophage recruitment to inflammatory stimuli in Hnrnpd tm1Rjsc mice. (a) Thioglycollate elicitation in wild-type (white bars) and
Hnrnpd tm1Rjsc littermates (black bars). Number of peritoneal macrophages (F4/80þ cells) in untreated (rest) and thioglycollate-injected (TG) mice. Each bar
represents mean±SD of four mice. (b) Thioglycollate elicitation in 129S6-Hnrnpd tm1Rjs (KO) and wild-type littermates (WT). Representative flow cytometric
analysis of peritoneal lavages performed 72 hours post-thioglycollate injection. Numbers indicate the percentage of F4/80þ -gated cells. (c) Peripheral blood
monocyte counts post-lipopolysacchride (LPS) challenge in wild-type (white bars) and Hnrnpd tm1Rjs (black bars) littermates. Monocytes were counted before
and 8 hours post-LPS challenge. Each bar represents mean±SD of three mice. *Po0.05.
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(dermatitis), as well as four minor criteria, including elevated
serum IgE levels, staphylococcal skin infection, conjunctivi-
tis, and xerosis (Hanifin and Rajka, 1980). We acknowledge
that further characterization of Hnrnpd tm1Rjsc mice is needed
before it can serve as model for human AD. However many
relevant features including, elevated number of dermal T
cells, mast cells, macrophages, and serum IgE levels, as well
as, eczematous epidermal changes, shift towards a Th2
microenvironment in acute lesions, pruritus, and sensitivity
to dexamethasone suggest the Hnrnpd tm1Rjsc mouse model
may be useful in the study of AD.
Several mouse models reproducing features of human AD
have been described, including NC/Nga mice (Matsuda et al.,
1997), transgenic mouse models with expression of human
APOC1 (Tg(APOC1)1Lmh) (Nagelkerken et al., 2008), and
targeted expression of IL4 (Tg(KRT14-Il4)1LuXu) (Chan et al.,
2001) or IL18 (Tg(KRT14-Il18)1Miz) (Konishi et al., 2002) to
the basal layer using a keratin 14 promoter. Hnrnpd tm1Rjsc
mice share several features with these models, including
pruritis, CD characterized by acanthotic epidermis, elevated
serum IgE levels, as well as dermal infiltrate of T cell, mast
cell, macrophage, and eosinophils. Hnrnpd tm1Rjsc mouse
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Figure 8. Subcutaneous injection of CCL27 and TNF in Hnrnpd tm1Rjsc mice results in eczematous dermatitis. (a–f) Representative skin samples from (a–c)
Hnrnpd tm1Rjsc mice and (d–f) wild-type littermates 10 days after injection with CCL27 and TNF. (g–l) Representative skin samples from (g–i) Hnrnpd tm1Rjsc mice
and (j–l) wild-type littermates 10 days after injection with MCP1. (a, d, g and j) H/E-stained, (b, e, h and k) T cells (CD3þ , red), and (c, f, i and l) macrophages
(F4/80þ , red). Nuclei are counterstained blue. Dotted line indicates the dermoepidermal border. Enlarged magnification of lesions (m) induced by CCL27
and TNF injection and (n) induced by MCP1 and TNF to highlight differences in histological presentation. Changes in (m) resemble chronic spongiotic
dermatitis, whereas changes in (n) more closely reflect interface dermatitis. Scale bar¼ 0.1 mm. (o) Number of mast cells per low-power field
(LPF, 100 magnification) in toluidine-stained sections. Each bar represents mean±SD of counts from three mice. *Po0.05.
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model, similar to other spontaneous models (Shiohara et al.,
2004), is hampered by lack of complete penetrance and
variability in the age of onset of dermatitis phenotype.
However, these limitations can be eased by using hapten-
induced models (Shiohara et al., 2004), as well as induced
models of dermatitis described in this report that will provide
a controlled setting to investigate the pathophysiology of
inflammatory lesions.
AD and allergic contact dermatitis are both eczematous
diseases mediated through immune mechanisms (Akhavan
and Cohen, 2003). Hnrnpd tm1Rjs mice exhibit a enhance CHS
response suggesting a greater susceptibility to hapten-specific
T-cell-mediated skin inflammation, such as allergic contact
dermatitis (Saint-Mezard et al., 2004). This report focuses on
similarities between the pruritic inflammatory skin disease in
Hnrnpd tm1Rjs mice and human AD mainly due to the
increased serum IgE levels and dermal mast cells in affected
mice. However, we acknowledge that the overlap in the
histopathology of human atopic and allergic contact derma-
titis as well as work from mice showing an important role for
IgE (Bryce et al., 2004) and mast cells (Yokozeki et al., 2003)
in CHS does not allow this distinction to be clearly made at
this time.
The lesions occurring in our Hnrnpd tm1Rjsc mice were
predominately seen in the facial region very similar to NC/
Nga (Matsuda et al., 1997) and Tg(KRT14-Il4)1LuXu (Chan
et al., 2001) mice. We speculate that the dominance of
lesions in the facial region of Hnrnpd tm1Rjs mice may be a
result of mechanical stress created by grooming, although we
can not rule out other possible environmental triggers,
including a pathological response to normal flora with age.
Once lesions are initiated the increased scratching presum-
ably aids in the progression of lesions. The background strain
of our Hnrnpd tm1Rjs mice may also contribute to the
predilection of periocular involvement. The 129P3/J, a
parental strain of our 129S6- or B6;129S6-Hnrnpd tm1Rjs
mice, and BALB/cBy, the background of Tg(KRT14-Il4)1LuXu
(Chan et al., 2001) mice, have been reported to have
increased incidence for ulcerative blepharitis (Sundberg
et al., 1991). Furthermore, the 129 strain has been reported
to exhibit more severe ocular changes and blepharitis in an
experimental model of systemic lupus erythematosus (Chan
et al., 1995). Although the 129 background may impact
susceptibility of periocular involvement, lesion are not
limited to presumably being initiated with periocular
involvement, as 25% of affected mice present with dermatitis
without periocular involvement.
We have previously shown that Hnrnpd-deficient
macrophages are unable to rapidly degrade TNF and IL1b
mRNAs following induction, leading to their overexpression
(Lu et al., 2006). Furthermore, we have also previously shown
that Hnrnpd preferentially binds to and controls the turnover
of a number of ARE-containing transcripts that contain
overlapping AUUUA pentamers (Lu et al., 2006). TNF,
IL1b, and IL2 mRNAs all contain overlapping AUUUA
pentamers (Halees et al., 2008) and are increased 24 hours
post-CHS elicitation in Hnrnpd tm1Rjs mice as compared to
wild-type littermates. The CHS studies in this report were
performed with DNFB, a hapten that has been previously
shown to predominantly elicit a Th1 response (Dearman
et al., 1997; Wang et al., 2000). Measurement of the ratio of
IL4 mRNA relative to IFN-g mRNA levels in DNFB-elicited
ears suggest that the inflammatory response in Hnrnpd tm1Rjs
mice is shifted towards a Th2 response. Future studies with a
hapten that predominantly elicit a Th2 response will better
allow the characterization of a Th2-mediated response as well
as Th2-specific cytokine mRNAs that may be regulated by
HNRNPD. The IL4 mRNA, a pivotal enhancer of the Th2
response, contains overlapping AUUUA pentamers (Halees
et al., 2008), is bound by HNRNPD (Yarovinsky et al., 2006),
and is suggested to be a target of Hnrnpd regulation (Sadri
et al., 2008). In agreement with a proposed role of HNRNPD
in
IL4 regulation, mice transgenic for murine IL4 (FVB/N-
Tg(Igh-Il4)1Led) developed blepharitis and periocular skin
inflammation when maintained in a pathogen-free facility
(Tepper et al., 1990) similar to Hnrnpd tm1Rjs mice. Hence,
future studies are needed to validate the role of HNRNPD
in the control of other cytokines encoded by ARE-containing
mRNAs with overlapping AUUUA pentamers, such as IL4
and IL12. In contrast to the CHS response associated
with a shift towards a Th2 response in Hnrnpd
tm1Rjsc mice
before onset of overt dermatitis, Hnrnpd tm1Rjsc mice with CD
elicit a CHS response that is more strongly shifted towards a
Th1 response. In addition, measurement of IL4 and IFN-g
mRNA levels from acute lesions in Hnrnpd tm1Rjsc mice
suggest that lesion formation and early progression is
associated with a shift towards a Th2 microenvironment.
Taken together, these results suggest a possible biphasic
response in Hnrnpd tm1Rjsc mice similar to that seen in AD
(Leung et al., 2004), in which a Th2 response predominates in
acute lesions followed by a switch to a Th1 response that
predominates in chronic lesions. Further in depth character-
ization of acute and chronic stage lesions will be important in
more closely evaluating the immunological environment (Th1
or Th2) of these lesions at various stages of disease
progression.
It is interesting to note that whereas TNF, IL1b, and IL2
mRNAs all contain the canonical AUUUA motif, the mRNAs
encoding MCP1 and IL1Ra do not. The canonical AUUUA
motif is not the only motif recognized by HNRNPD, however,
and we have confirmed reports that HNRNPD controls the
stability of p21, a mRNA that does not contain this classical
motif (Lal et al., 2004). Furthermore, a screen for AUF1
ligands in mitogen-activated peripheral blood mononuclear
cells revealed MCP1, IL1Ra, and p21 as targets of HNRNPD
(Bhattacharya et al., 1999). It is believed that ARE flanking
sequences and higher order structural determinants formed
by mRNAs are also important in determining the binding of
ARE-binding proteins to AREs, and may explain the diversity
of AUF1 targets (Barreau et al., 2005). Conversely, the
differences in expression in CHS studies could result from
secondary affects due to altered expression of direct
HNRNPD targets, such as TNF and IL1b, which have been
shown to have a direct impact on the expression of IL6,
MCP1, and IL1Ra (Gu et al., 1999; Palmer et al., 2007). The
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generation of Tnfrsf1a*Il1r1*Hnrnpd triple knockout mice
will help to address this question.
CCL27 is produced by keratinocytes and serves as a skin-
specific chemokine for T cells that express CCR10 (Homey
et al., 2002). Subcutaneous injection of recombinant CCL27
has been shown to induce the recruitment of T cells to the site
of injection (Homey et al., 2002). Although the direct role of
CCL27 in human AD has not been established, recent studies
suggest CCL27 may be involved in skin inflammation in
human AD. Lesions of human AD show increased expression
of CCL27 expression (Homey et al., 2002). Furthermore,
serum levels of CCL27 are elevated in patients with AD
(Kakinuma et al., 2003; Hon et al., 2004) and the elevation is
correlated with disease severity (Hon et al., 2004). In
addition, subcutaneous injection of neutralizing antibodies
to CCL27 in early AD-like lesions in the Tg(KRT14-Il4)1LuXu
mouse model resulted in reduced clinical progression of
inflammation accompanied with reduced number of T and
mast cells, as well as, decreased epidermal acanthosis (Chen
et al., 2006). Although a large infiltration of T cells could be
seen with intradermal injection of CCL27 in Hnrnpd tm1Rjs
mice, few dermal macrophages and mast cells were seen and
epidermal changes were not observed. However, intradermal
injection of CCL27 and TNF in Hnrnpd tm1Rjs mice results in
eczetamous dermatitis with a large dermal infiltrate of T cells,
macrophages, and mast cells closely resembling spontaneous
dermatitis seen in Hnrnpd tm1Rjs mice. These data suggest that
both CCL27-responsive T cells and a proper proinflammatory
environment, as created by TNF, are important in leading to
subsequent leukocyte infiltration and epidermal morphologi-
cal changes in Hnrnpd tm1Rjs mice. Proinflammatory cyto-
kines, such as TNF, are important in endothelial activation
resulting in the expression of adhesion molecules that enable
leukocyte infiltration (de Vries et al., 1998), as well as
activating keratinocytes to produce chemokines and undergo
morphological changes (Banno et al., 2004). Differences seen
in functional properties of Hnrnpd-deficient T cells and
macrophages suggest altered inflammatory and immunologi-
cal pathways in Hnrnpd tm1Rjsc mice that may predispose
these mice to inflammatory skin lesions. Furthermore,
induced lesions by CCL27 and TNF injection share simila-
rities with our current understanding of the early events of
human AD. These early events have been characterized by
an upregulation of proinflammatory cytokines, TNF and IL1b,
that together with chemokines lead to the recruitment of
different subset of leukocytes, including CCL27-responsive T
cells (Avgerinou et al., 2008). Hence, our experimentally
induced model in Hnrnpd tm1Rjsc mice provides a controlled
assay to further study the initiation events, progression, and
pathophysiology of these inflammatory lesions.
In summary, the Hnrnpd tm1Rjsc mouse model exhibiting
pruritic inflammatory skin disease, enhanced CHS, and
experimentally induced dermatitis will help in investigating
the targets of Hnrnpd and the consequence of aberrant
mRNA turnover of these targets in regulating skin inflamma-
tion. This understanding may provide insight into the
pathophysiology and therapeutic strategy of similar human
dermatoses, such AD.
MATERIALS AND METHODS
Mice
The B6;129S6- and 129S6-Hnrnpd tm1Rjsc and corresponding wild-
type mice were derived and genotyped as previously described (Lu
et al., 2006). Chimeric founder males were breed with C57BL/6 (B6)
wild-type females to generate heterozygotes on a mixed B6;129S6.
These heterozygotes were crossed to produce Hnrnpd tm1Rjsc homo-
zygotes and wild-type littermates on a mixed B6;129S6 background.
All mice are kept under specific pathogen-free conditions. All animal
protocols were approved by the NYU Institutional Animal Care and
Use Committee.
Immunohistochemistry, immunofluorescence staining, and flow
cytometry
Paraffin-embedded skin specimens were stained with antibodies to
PY-Stat3 (Cell Signaling Technology, Danvers, MA) as described
(Sadri et al., 2008). Frozen sections were stained with antibodies
specific to F4/80 (BM8), CD3e (17A2), CD31 (390), and Gr-1 (RB6-
8C5) (eBioscience, San Diego, CA). In some sections, nuclei were
counterstained with ToPro3 (Molecular Probes, Carlsbad, CA). For
eosinophil identification frozen sections were pretreated with 10 mM
potassium cyanide solution to block myeloperoxidase activity and
then eosinophil peroxidase was probed for with DAB-Ni. Cells from
spleens, lymph nodes, and peritoneal lavage were stained as
described (Lu et al., 2006) with antibodies from Pharmingen (BD
Biosciences, San Jose, CA) to CD4 (GK1.5) and CD8 (53–6.72),
antibodies from eBioscience to CD3e (145-2C11), TCRb (H57-597),
and F4/80 (BM8). Samples were analyzed using a FACSCalibur
flow cytometer (BD Biosciences) and FlowJo software (TreeStar,
Ashland, OR).
ELISA
For serum IgE levels, microtiter plates were coated with anti-mouse
IgE (R35-72; Pharmingen), followed by sequential incubation of
serially diluted purified mouse IgE (C38-2; Pharmingen) or sera from
mice (tested at 1:100, 1:1,000, and 1:10,000 dilutions), biotinylated
anti-mouse IgE (23G3; eBioscience), streptavidin-HRP (eBioscience),
and then TMB substrate solution (eBioscience). Total serum levels
were calculated using standard curve generated from optical density
readings at 450 nm for purified mouse IgE.
Mouse CHS model
After being anesthetized with ketamine, healthy B6;129S6-
Hnrnpd tm1Rjsc and littermate sex-matched wild-type mice 6 months
of age were sensitized on shaved abdomen skin with 30 ml of
0.5%. DNFB (Sigma) in 4:1 acetone and olive oil solution (A/O). At 5
days after sensitization, the mice were challenged on each side of
the right ear with 10 ml of 0.2% DNFB in A/O solution. As the
control, 10 ml of A/O solution was added to each side of the
left ear. At 24 hours after challenge the thickness of the ear
was measured using an engineer’s micrometer (Ozaki Manufactur-
ing, Tokyo, Japan). For the determination of the effect of SB203580
(#599389, Calbiochem, Gibbstown, NJ), 10 ml of 10 mM SB203580
diluted in A/O solution was applied to each side of the right ear of
sensitized mice 30 minutes before challenge. As a control, left ears
were pretreated before challenge with A/O solution. Samples from
ears 24 hours after challenge were used for qRT-PCR cytokine
detection and immunohistochemistry.
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For assaying the role of Hnrnpd on the afferent phase of CHS,
B6;129S6-Hnrnpd tm1Rjsc and littermate sex-matched wild-type mice
6 months of age were sensitized with 0.5% DNFB on shaved
abdomen and ears. Pooled purified T cells (by negative selection
with B220þ and Mac1þ microbeads and MACS system; Miltenyi
Biotec, Auburn, CA) from draining lymph nodes of each group were
injected into the base of the ear (105 T cells in 10 ml of PBS) of naı¨ve
B6;129S6 wild-type mice 8 months of age. CHS was elicited and
measured as described above.
For assaying the role of Hnrnpd on the efferent phase of CHS,
wild-type B6;129S6 mice 6 months of age were sensitized with 0.5%
DNFB. Pooled purified T cells (by negative selection as stated above
with MACS system) from draining lymph nodes were injected into
the base of the right ear (105 T cells in 10 ml of PBS) of naı¨ve
B6;129S6-Hnrnpd tm1Rjsc and littermate sex-matched wild-type mice
6 months of age. Pooled T cells from unsensitized donor mice were
injected into the left ears of naı¨ve recipients as controls. CHS was
elicited and measured as described above.
RT–PCR detection of cytokine and chemokine mRNAs
Samples were taken from control and challenged ears 24 hours after
challenge, homogenized in Trizol (Invitrogen, Carlsbad, CA) and
mRNA was extracted according to manufacturer’s instructions.
Cytokine and chemokine levels were determined by qRT-PCR using
the Roche LightCycler system with a SYBR-Green Master kit (Roche
Molecular Biochemicals, Mannheim, Germany), and gene-specific
primers are available upon request. CT values were used to calculate
relative values and were normalized to CT values for cyclophilin A
and HPRT. The normalized value for a given transcript from the ear
of an Hnrnpd tm1Rjsc mouse was compared to that of its wild-type
littermate. For calculations of the ratio of IFN-g to IL4 mRNA levels,
mRNA was extracted from 4 mm punch biopsies or ears as described
above. The CT value for IFN-g was normalized to the CT value for IL4
for each sample and the DDCT method was used to calculate ratios.
Proliferation assays and IL2 ELISA
To trace cell division, lymph node and spleen cells were purified
from 4-month-old B6;129S6 mice and labeled with 10mM CSFE
(Molecular Probes) at room temperature for 10 minutes. Cells were
washed in complete RPMI 1,640 media (Lu et al., 2006) and
stimulated in 12-well plates (5 105 cells per well) coated with anti-
CD3e (145-2C11; eBioscience) at concentrations of 0.04, 0.2, 1, and
5mg ml1 for 24 or 72 hours. Progression of cell division was
determined by flow cytometry after cell-surface staining with
antibodies to CD4 and CD8. In [3H]thymidine proliferation assays,
splenocyte T cells were purified by using antibody-bead depletion
using B220 microbeads, followed by positive selection with CD4
microbeads (MACS). Purified CD4þ T cells resuspended in complete
RPMI 1,640 media were plated in triplicate in 96-well plate coated
with various concentrations of anti-CD3e (145-2C11; eBioscience)
and anti-CD28 (37.15; eBioscience) for 48 hours. During the last
8 hours the cultures were pulsed with 1 mCi per well [3H]thymidine,
and cells were then harvested onto glass-fiber filters, and thymidine
incorporation was measured using a scintillation counter. To
measure IL2 production, lymph node and spleen cells were purified
and stimulated in 48-well plates (1 105 cells per well) coated with
anti-CD3e (145-2C11; eBioscience) at concentrations of 0, 0.04, 0.2,
1, and 5 mg ml1 for 24 hours. Supernatants were collected and
mouse IL2 ELISA (eBioscience) was performed according to
manufacturer’s instructions.
Hnrnpd expression was knocked down in Jurkat T cells using a
control and Hnrnpd-directed shRNAmir retroviral vectors (Open
Biosystems, Huntsville, AL) according to manufacturer’s instructions.
Immunoblot analysis was performed following standard protocols
with antibodies to Hnrnpd (995), HuR (3A2), and TIAR (C-18) from
Santa Cruz Biotechnology (Santa Cruz, CA). For IL2 production
studies, Jurkat T cells were stimulated in 96-well plates (1 105 cells
per well) coated with anti-CD3 (OKT-3; eBioscience) and treated
with phorbol myristate acetate (PMA) (10 ng ml1). Supernatants
were collected and human IL2 ELISA (eBioscience) was performed
according to manufacturer’s instructions.
Macrophage recruitment
Mice were administered 1 ml of 4% thioglycollate broth i.p., and
72 hours later were killed. Cells were recovered by peritoneal
lavage, counted using a hemocytometer, stained with an antibody to
F4/80 (BM8), and analyzed by flow cytometry as described (Lu et al.,
2006). The number of macrophages was calculated based on
proportion of F4/80þ cells. For systemic macrophage recruitment
assay, mice were injected i.p. with LPS (20 mg g1), tail bleed at
4 hours, and 8 hours later were killed. Monocyte counts were
performed on blood samples collected 8 hours post-LPS challenge
(Ani Lytics Inc., Gaithersburg, MD). MCP1 levels were measured on
serum from samples 4 hours after challenge using Mouse Cytokine
Array blots (RayBiotech Inc., Norcross GA) according to the
manufacturer’s instructions.
Intradermal injections with MCP1, TNFa, and CCL27
B6;129S6-Hnrnpd tm1Rjsc and wild-type littermate mice 8–12 months
of age that showed no dermatitis were subcutaneously injected with
either CCL27 (2.5 mg; PeproTech, Rocky Hill, NJ), CCL27
(2.5 mg)þ rat rTNF (5,000 U; PeproTech), rJE/MCP1 (0.2 mg; Pepro-
Tech), rJE/MCP1 (0.2mg)þ rTNF (5,000 U), rTNF (5,000 U), or PBS
control diluted in 100 ml of PBS at six specific and separate spots on
their dorsum. At 10 days after treatment, mice were killed, and
injected sites were excised and examined by immunohistochemistry
and immunoflourescence.
Administration of dexamethasone
Dexamethasone (2mg g1; Phoenix Scientific, St. Joseph, MO) was
administered s.q. everyday to back scruff for a period of 5 days and
treated in tapering dose regimen (sequential twofold decrease for 4
days) until they were no longer treated. Other mice were treated
daily with topical application of Panalog Cream (Triamcinolone; Fort
Dodge Animal Health, Fort Dodge, IA) for 7 days. The progression
and severity of lesions was observed daily during and for 2 weeks
post-treatment for both topical and subcutaneous treatment groups.
Statistical analysis
Data are presented as mean±SD for statistical comparison of two
samples, the two-tailed Student’s t-test was used for evaluation.
Incidence of dermatitis was presented by Kaplan–Meier and
significance was evaluated using Log-rank test.
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SUPPLEMENTARY MATERIAL
Figure S1. Hnrnpd and Stat3 expression in the skin of Hnrnpd tm1Rjsc mice.
Figure S2. Stat3 phosphorylation and T-cell staining in chemokine-stimulated
skin of Hnrnpd tm1Rjsc mice.
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